In conclusion, the present study identified a novel anti-tumor effect of butyrate, which exerts by suppressing PD-L1 transcription via STAT1 acetylation, providing scientific information to understand the pivotal role of butyrate in tumor immunity. Here, CD274 is linked to neoplasm.